PUBLIC UPDATES, IN CONTEXT
Research, personal or team milestones, and company announcements — each with its own category and original source.
Syneron Bio announced a $150 million Series B financing to advance its Synova macrocyclic peptide discovery platform and support its pipeline’s progression toward clinical development.
Read original source ↗Source: Syneron BioSyneron Bio announced nearly $100 million across its Series A and A+ financing rounds. This is a company financing announcement.
Read original source ↗Source: Syneron BioSyneron Bio announced a strategic collaboration with AstraZeneca on macrocyclic peptide therapies for chronic diseases. The announcement does not establish clinical efficacy.
Read original source ↗Source: Syneron BioRuochi Zhang was a member of the Feng Ya team recognized for a fair-diagnosis proposal on maternal morbidity, demonstrated through stillbirth prediction.
Read original source ↗Team roster & project ↗Source: NIH / NICHD